Works matching IS 00099236 AND DT 2001 AND VI 69 AND IP 1
Results: 10
Definition and axioms of net treatment benefit.
- Published in:
- Clinical Pharmacology & Therapeutics, 2001, v. 69, n. 1, p. 1, doi. 10.1067/mcp.2001.112690
- By:
- Publication type:
- Article
Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2001, v. 69, n. 1, p. 72, doi. 10.1067/mcp.2001.112688
- By:
- Publication type:
- Article
Determination of pregnancy outcome risk rates after exposure to an intervention<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2001, v. 69, n. 1, p. 7, doi. 10.1067/mcp.2001.112364
- By:
- Publication type:
- Article
Seville orange juice-felodipine interaction: Comparison with dilute grapefruit juice and involvement of furocoumarins<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2001, v. 69, n. 1, p. 14, doi. 10.1067/mcp.2001.113185
- By:
- Publication type:
- Article
The pharmacokinetics and metabolic disposition of tacrolimus: A comparison across ethnic groups<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2001, v. 69, n. 1, p. 24, doi. 10.1067/mcp.2001.113183
- By:
- Publication type:
- Article
Pharmacokinetic interaction between single oral doses of ditiazem and sirolimus in healthy volunteers<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2001, v. 69, n. 1, p. 32, doi. 10.1067/mcp.2001.112513
- By:
- Publication type:
- Article
Fluvoxamine inhibits the CYP2C9 catalyzed biotransformation of tolbutamide<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2001, v. 69, n. 1, p. 41, doi. 10.1067/mcp.2001.112689
- By:
- Publication type:
- Article
Pharmacokinetics of nicotine in healthy elderly people.
- Published in:
- Clinical Pharmacology & Therapeutics, 2001, v. 69, n. 1, p. 57, doi. 10.1067/mcp.2001.113181
- By:
- Publication type:
- Article
ADL 8-2698, a trans-3,4-dimethyl-4- (3-hydroxyphenyl) piperidine, prevents gastrointestinal effects of intravenous morphine without affecting analgesia<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2001, v. 69, n. 1, p. 66, doi. 10.1067/mcp.2001.112680
- By:
- Publication type:
- Article
Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: Pharmacokinetics, exposure-response relationships, and influence on cyclosporine<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2001, v. 69, n. 1, p. 48, doi. 10.1067/mcp.2001.112969
- By:
- Publication type:
- Article